Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
about
Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazideAminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosisLong-Term Effects of (-)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats2-Thioxanthines Are Mechanism-based Inactivators of Myeloperoxidase That Block Oxidative Stress during InflammationPotent Reversible Inhibition of Myeloperoxidase by Aromatic HydroxamatesInhibition of myeloperoxidase by benzoic acid hydrazidesNitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammationFormation of reactive sulfite-derived free radicals by the activation of human neutrophils: an ESR studyRational drug design applied to myeloperoxidase inhibition.Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxidesInhibition of ascorbate peroxidase by salicylic acid and 2,6-dichloroisonicotinic acid, two inducers of plant defense responses.Myeloperoxidase-derived oxidation: mechanisms of biological damage and its preventionDapsone in dermatology and beyondAirway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activity.Metabolism of drugs by leukocytes.ESR and X-ray Structure Investigations on the Binding and Mechanism of Inhibition of the Native State of Myeloperoxidase with Low Molecular Weight FragmentsThe role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions.Myeloperoxidase: a target for new drug development?Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.Posttranslational protein modifications by reactive nitrogen and chlorine species and strategies for their prevention and elimination.Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity.Characterization of chemical features of potent myeloperoxidase inhibitors.On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs.Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.The impact of various reactive oxygen species on the formation of neutrophil extracellular traps.Peroxidative metabolism of beta2-agonists salbutamol and fenoterol and their analogues.Promotion of thyroid carcinogenesis by para-aminobenzoic acid in rats initiated with N-bis(2-hydroxypropyl)nitrosamine.N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor.In vitro activation of dibromoacetonitrile to cyanide by myeloperoxidase.Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine.Flavonoids and 5-aminosalicylic acid inhibit the formation of neutrophil extracellular traps.Hydrogen peroxide activates agonist-sensitive Ca(2+)-flux pathways in canine venous endothelial cellsPhenylbutazone radicals inactivate creatine kinase.Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.Superoxide-dependent oxidation of melatonin by myeloperoxidase.
P2860
Q24530040-C24C66F0-DD89-48F4-8EBA-335A98C9F8B9Q24680255-C6133D2E-68C9-4A55-8E39-E62517E1392BQ27316058-2F84B2A6-26DD-47BD-A32D-57DD98F94A0FQ27672618-34CCDC53-72BA-40C2-88F2-4433AD594523Q27680535-32E881F6-263D-4D51-9F09-A22EF2482D98Q28368133-E913E902-A78B-4969-A177-270635F08151Q28376896-6342E2CA-5FD9-4871-9BC1-2C89457C665DQ28730931-FACE482E-B971-45CA-ADBB-72B1C5195C27Q30372838-98D704DC-CB62-4081-9BE9-953682BDB4C9Q33759336-EE63167C-8F69-4206-8A27-16BB657BB71EQ33772833-34EAD1A5-7C42-4EB0-9BBA-092B6424A3D0Q34162955-6F19930C-505D-4DB4-B4D9-F3027CF297B8Q34390020-FBD2F5EB-9DF8-4E02-A8F1-112D411C9D25Q34552120-35851636-307B-402D-B0B4-E2E50D0D3607Q34945908-B9C1BB15-3807-4BCF-83E5-FA77833B1048Q35889624-FCB37119-BA16-4F90-B459-38337CC70A95Q36312078-51EB48C7-0B76-44EA-B2FD-BF711FB517BAQ36860606-714E2DBA-719B-4CE2-848D-78663C1B5794Q37101754-A28663D7-C3CB-41AC-89B8-6E942898701BQ37398673-5CA511FD-0644-4169-95FB-13FD0545590BQ37799603-3C02907C-DE12-44F0-B18A-3C6C2E98B330Q38100263-E85CD826-5686-4FBE-B4C5-7155B4255DE9Q38239610-51EA8A6B-BB4F-4842-9CE2-AB1983EA88B7Q38344922-895D7131-26C5-4406-8037-A5F6B3700461Q38842921-DFD38AB4-1F2F-4E15-A341-9FF228586082Q40762827-C9030402-F1D0-41F7-8A1C-75A25C8DDBEEQ40785532-7231B70E-DAAC-4E57-9007-2F28A42E2BB5Q42033248-C9CD3920-0F8B-4632-9A02-416B1E7CB753Q42045582-E5F72CE7-072E-4F35-850B-ED44C6CBB4FEQ42477208-9452BF64-508A-4C9C-87AD-5C50C2CB5CA0Q42657336-1DFE61C6-F37E-4D0E-BDA3-BAAC47B89B17Q42702823-D58D1C5D-746D-4AC5-8739-560DEDA0E6CFQ42739533-9C1619E1-FFAA-43C3-B33F-13607CEB9A54Q42761449-F10F0D0C-7F7D-4AB4-B5A7-CAC4BC196F00Q42777741-21C01EAF-A654-4D91-A787-7603C553198DQ42832440-705B85D1-8815-4C97-92C0-36D03786748DQ43551447-644AC301-6480-49D6-B91B-46F3ACEB12E3Q45338276-446209E2-09CA-46E0-BB05-5EA921A92C5FQ46485649-35689DC2-F57E-422C-89C6-E9BB989FFCD4Q46691136-BB00F3B8-1469-4B69-8A57-D2398EED81EB
P2860
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@ast
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@en
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@nl
type
label
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@ast
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@en
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@nl
prefLabel
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@ast
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@en
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@nl
P1476
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
@en
P2093
Winterbourn CC
P304
P356
10.1016/0006-2952(91)90565-M
P407
P577
1991-05-01T00:00:00Z